Exacerbations · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Exacerbations (number of people experiencing ≥ 1 exacerbations) · patients with chronic obstructive pulmonary disease
It is very uncertain whether remote monitoring plus usual care changes number of people experiencing 1 or more exacerbations compared with usual care (very low certainty).
1 finding from 1 review
Exacerbations · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
COPD exacerbations · patients with chronic obstructive pulmonary disease
Exacerbations · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Exacerbations · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Exacerbations · autumn asthma exacerbations in children
Omalizumab probably leads to lower exacerbations compared with usual care (moderate certainty).
3 findings from 1 review
OR 0.48 [0.25, 0.92]
1 study · 348 participants
Moderate
OR 0.37 [0.17, 0.81]
1 study · 184 participants
Moderate
OR 0.63 [0.22, 1.79]
1 study · 164 participants
Moderate
Exacerbations · autumn asthma exacerbations in children
The review found no eligible studies for this question.
2 findings from 1 review
Exacerbations · autumn asthma exacerbations in children
A boost of inhaled corticosteroids showed no clear difference in exacerbations compared with usual care (moderate certainty).
1 finding from 1 review
Exacerbations · autumn asthma exacerbations in children
The review found no eligible studies for this question.
2 findings from 1 review
Asthma exacerbations · people with asthma
Shared decision‐making showed no clear difference in exacerbations of asthma ( compared with usual care (low certainty).
1 finding from 1 review
Exacerbations requiring antibiotics · people with non‐cystic fibrosis bronchiectasis
The review found no eligible studies for this question.
1 finding from 1 review
Exacerbation requiring OCS Weighted mean duration of studies: 25 weeks · people with asthma
Enhanced education showed no clear difference in exacerbations requiring at least OCS 26 weeks compared with control versus usual care (low certainty).
1 finding from 1 review
Exacerbations (number of people experiencing ≥ 1 exacerbations) · patients with chronic obstructive pulmonary disease
It is very uncertain whether remote monitoring changes number of people experiencing 1 or more exacerbations compared with usual care (very low certainty).
1 finding from 1 review
Exacerbations (number of people experiencing ≥ 1 exacerbations) · COPD and at least one other long‐term condition
It is very uncertain whether intervention changes exacerbations ‐ number of people experiencing one or more  compared with usual care (very low certainty).
1 finding from 1 review
Exacerbation: hospital 17 weeks · children with asthma
1 finding from 1 review
Mean exacerbations requiring a course of oral corticosteroids · adults and adolescents with asthma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Asthma exacerbations · people with asthma
Digital adherence interventions may leads to lower asthma exacerbations ‐ Number of people with one or more exacerbations compared with usual care (low certainty).
1 finding from 1 review
Exacerbations (number of people experiencing ≥ 1 exacerbations) · the management of chronic obstructive pulmonary disease
It is very uncertain whether multi‐component intervention changes exacerbations: number of people experiencing at least one exacerbation compared with other intervention or routine, usual care or control treatment (very low certainty).
1 finding from 1 review